272 related articles for article (PubMed ID: 17638888)
21. Functional interaction of CCAAT/enhancer-binding-protein-α basic region mutants with E2F transcription factors and DNA.
Kowenz-Leutz E; Schuetz A; Liu Q; Knoblich M; Heinemann U; Leutz A
Biochim Biophys Acta; 2016 Jul; 1859(7):841-7. PubMed ID: 27131901
[TBL] [Abstract][Full Text] [Related]
22. A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.
Lourenço AR; Coffer PJ
Oncogene; 2017 Sep; 36(37):5221-5230. PubMed ID: 28504718
[TBL] [Abstract][Full Text] [Related]
23. Keratin 10 gene expression during differentiation of mouse epidermis requires transcription factors C/EBP and AP-2.
Maytin EV; Lin JC; Krishnamurthy R; Batchvarova N; Ron D; Mitchell PJ; Habener JF
Dev Biol; 1999 Dec; 216(1):164-81. PubMed ID: 10588870
[TBL] [Abstract][Full Text] [Related]
24. CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma.
Tan EH; Hooi SC; Laban M; Wong E; Ponniah S; Wee A; Wang ND
Cancer Res; 2005 Nov; 65(22):10330-7. PubMed ID: 16288022
[TBL] [Abstract][Full Text] [Related]
25. Decreased survival of C/EBP beta-deficient keratinocytes is due to aberrant regulation of p53 levels and function.
Yoon K; Zhu S; Ewing SJ; Smart RC
Oncogene; 2007 Jan; 26(3):360-7. PubMed ID: 16832342
[TBL] [Abstract][Full Text] [Related]
26. C/EBPα expression is downregulated in human nonmelanoma skin cancers and inactivation of C/EBPα confers susceptibility to UVB-induced skin squamous cell carcinomas.
Thompson EA; Zhu S; Hall JR; House JS; Ranjan R; Burr JA; He YY; Owens DM; Smart RC
J Invest Dermatol; 2011 Jun; 131(6):1339-46. PubMed ID: 21346772
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the C/EBPα signaling pathway in acute myeloid leukemia (Review).
Song G; Wang L; Bi K; Jiang G
Oncol Rep; 2015 May; 33(5):2099-106. PubMed ID: 25760953
[TBL] [Abstract][Full Text] [Related]
28. C/EBPα in normal and malignant myelopoiesis.
Friedman AD
Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
[TBL] [Abstract][Full Text] [Related]
29. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
30. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
[TBL] [Abstract][Full Text] [Related]
31. C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event.
Messenger ZJ; Hall JR; Jima DD; House JS; Tam HW; Tokarz DA; Smart RC
Cell Death Dis; 2018 Oct; 9(11):1054. PubMed ID: 30323292
[TBL] [Abstract][Full Text] [Related]
32. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.
Capozza F; Williams TM; Schubert W; McClain S; Bouzahzah B; Sotgia F; Lisanti MP
Am J Pathol; 2003 Jun; 162(6):2029-39. PubMed ID: 12759258
[TBL] [Abstract][Full Text] [Related]
33. Airway epithelial cell differentiation during lung organogenesis requires C/EBPα and C/EBPβ.
Roos AB; Berg T; Barton JL; Didon L; Nord M
Dev Dyn; 2012 May; 241(5):911-23. PubMed ID: 22411169
[TBL] [Abstract][Full Text] [Related]
34. Dual negative roles of C/EBPα in the expansion and pro-tumor functions of MDSCs.
Mackert JR; Qu P; Min Y; Johnson PF; Yang L; Lin PC
Sci Rep; 2017 Oct; 7(1):14048. PubMed ID: 29070836
[TBL] [Abstract][Full Text] [Related]
35. Growth-inhibiting activity of transcription factor C/EBPalpha, its role in haematopoiesis and its tumour suppressor or oncogenic properties in leukaemias.
Fuchs O
Folia Biol (Praha); 2007; 53(3):97-108. PubMed ID: 17580000
[TBL] [Abstract][Full Text] [Related]
36. CUGBP1 promotes cell proliferation and suppresses apoptosis via down-regulating C/EBPα in human non-small cell lung cancers.
Lu H; Yu Z; Liu S; Cui L; Chen X; Yao R
Med Oncol; 2015 Mar; 32(3):82. PubMed ID: 25701464
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation.
Rishi L; Hannon M; Salomè M; Hasemann M; Frank AK; Campos J; Timoney J; O'Connor C; Cahill MR; Porse B; Keeshan K
Blood; 2014 Apr; 123(15):2389-400. PubMed ID: 24516045
[TBL] [Abstract][Full Text] [Related]
39. The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest.
Müller C; Calkhoven CF; Sha X; Leutz A
J Biol Chem; 2004 Feb; 279(8):7353-8. PubMed ID: 14660596
[TBL] [Abstract][Full Text] [Related]
40. Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha.
Wu FY; Tang QQ; Chen H; ApRhys C; Farrell C; Chen J; Fujimuro M; Lane MD; Hayward GS
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10683-8. PubMed ID: 12145325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
